Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study. [electronic resource]
Producer: 20191230Description: 439-448 p. digitalISSN:- 1535-7228
- Adult
- Antipsychotic Agents -- therapeutic use
- Bipolar Disorder -- drug therapy
- Depression -- drug therapy
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Piperazines -- therapeutic use
- Receptor, Serotonin, 5-HT1A
- Receptors, Dopamine D2 -- agonists
- Receptors, Dopamine D3 -- agonists
- Serotonin 5-HT1 Receptor Agonists -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.